| Patient Safety |
1 |
1 |
| Geriatrics |
0 |
0.99 |
| Nonsteroidal Anti-Inflammatory Agents |
0 |
0.42 |
| Pain Management |
0 |
0.42 |
| Thromboembolism |
0 |
0.34 |
| Cardiovascular Risk Management |
0 |
0.27 |
| Benzodiazepines |
0 |
0.24 |
| Cerebrovascular Accident |
0 |
0.22 |
| Coronary Artery Disease (CAD) |
0 |
0.21 |
| Heart Failure (HF) |
0 |
0.21 |
| Antipsychotics |
0 |
0.19 |
| Atrial Fibrillation |
0 |
0.17 |
| Atypical Antipsychotics |
0 |
0.17 |
| Aspirin |
0 |
0.14 |
| Cardiovascular disease |
0 |
0.14 |
| Dementia |
0 |
0.14 |
| Traumatic Brain Injury |
0 |
0.13 |
| Adverse Effects |
0 |
0.1 |
| Cognitive Impairment |
0 |
0.1 |
| Heart |
0 |
0.1 |
| Impairment |
0 |
0.1 |
| Pulmonary Embolism |
0 |
0.1 |
| Sulfonylureas |
0 |
0.1 |
| Type 2 Diabetes Mellitus |
0 |
0.1 |
| Bipolar Disorder |
0 |
0.08 |
| Depression |
0 |
0.08 |
| Deep Venous Thrombosis |
0 |
0.07 |